International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Loading Events

« Back to All Events

  • This event has passed.

Symposium: Getting Real (World) with Psoriasis: Advances in Registries and Real-World Data in Psoriasis

Date:
May 18
Event Category:
WATCH NOW

Agenda

PART I: LECTURES

Introduction to the IPC and Program Overview

Joel Gelfand

Real-World Data Using Medical and Administrative Records

April Armstrong

Registries and Psoriasis: An Industry Perspective

Steven Fakharzadeh

Real-World Data and Psoriasis: A European Perspective

Nick Reynolds

PART II: KEYNOTE

Innovations in Real-World Data

Alexis Ogdie

Panel Discussion

Joel Gelfand & Faculty

PART III: POSTER PRESENTATIONS

Your Pores and the Outdoors: Investigating the Association between Pollution and Inflammatory Dermatological Diseases

Manan Mehta, BS, – University of Southern California Keck School of Medicine, Los Angeles, California, United States

Understanding Health Disparities among Patients with Psoriasis: Results from National Psoriasis Foundation Annual Surveys 2019 – 2021

George Gondo, MA – National Psoriasis Foundation, Portland, Oregon, United States

Psoriasis Resolution in Challenging Body Areas with Lxekizumab: Response Trajectories by Patient Profile Clusters Over Time

Andrew Blauvelt, MD, MBA – Oregon Medical Research Center, Portland, Oregon, United States

The Patient Perspective on Vaccine Uptake in Adults with Psoriasis and Eczema

Megan H. Noe, MD, MPH, MSCE – Brigham and Women’s Hospital, Boston, Massachusetts, United States

Kullback-Leibler Divergence Model to Integrate Genetic and Genomic Information to Assess Drug Response for Psoriatic Patients

Qinmengge Li, BS, MS – University of Michigan, Ann Arbor, Michigan, United States

A Systems Biology Analysis of Peripheral Blood and Cell Subsets from Patients with Psoriasis and Psoriatic Arthritis Reveals Biological Sex-Based Endotypes

Cheryl Cameron, PhD – Case Western Reserve University, Cleveland, Ohio, United States

HDL Composition, Particle Number and Size is Associated with Non-Calcified Coronary Plaque in Psoriasis

Álvaro Gonzales-Cantero, MD, PhD – Hospital Ramón y Cajal, Madrid, Spain

A Novel Expression Based, Non-Invasive Method to Differentiate Atopic Dermatitis and Psoriasis

Michael D Howell, PhD – DermTech Inc., La Jolla, California, United States

Closing Comments and Adjourn

Joel Gelfand

 

WATCH NOW

 

Program Chair

Joel Gelfand, MD, MSCE

University of Pennsylvania

Philadelphia, Pennsylvania, United States

IPC Board Member

Bio

Program Faculty

April Armstrong, MD, MPH

Keck School of Medicine, USC

Studio City, California, United States

Bio

Nick Reynolds, BSc, MBBS, MD, FRCP

Newcastle University

Newcastle upon Tyne, United Kingdom

Bio

Supported in part by lead sponsor, Eli Lilly and Company, and supporting sponsors, Bristol Myers Squibb and Dermavant.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.